期刊文献+

反义锁核酸与拉米夫定在HepG2.2.15细胞中抗HBV作用的比较

Inhibitory effect of locked nucleic acid antisense oligonucleotides versus lamivudine on HBV replication in HepG2.2.15 cells
下载PDF
导出
摘要 目的:应用反义锁核酸与拉米夫定作用HepG2.2.15细胞,对他们抗乙型肝炎病毒(hepatitis B virus,HBV)效果进行比较.方法:设计针对HBV翻译起始区S基因mRNA的反义寡核苷酸,并进行锁核酸修饰,以阳离子脂质体介导反义锁核酸转染HepG2.2.15细胞;拉米夫定组直接作用HepG2.2.15细胞;分别于用药后第2、4、6、8、10天收集细胞培养上清液.用ELISA法和FQ-PCR法检测收集上清液HBsAg、HBeAg和HBVDNA的含量.MTT法分别检测反义锁核酸与拉米夫定对细胞存活率的影响.结果:拉米夫定对HBVDNA具有明显抑制作用,最高可达46.52%,但对HBsAg、HBeAg影响较小;反义锁核酸对HBsAg、HBeAg及HBVDNA均有较强抑制作用,对HBsAg、HBeAg和HBVDNA的最高抑制率分别达67.69%、59.71%和62.96%(P<0.05),且抑制随时间呈增高趋势.反义锁核酸与拉米夫定对细胞代谢均无明显影响.结论:反义锁核酸抗HBV作用机制与拉米夫定不同,反义锁核酸抗HBV作用明显优于拉米夫定. AIM:To compare the inhibitory effect of locked nucleic acid antisense oligonucleotides(antisense-LNA) and lamivudine on HBV replication in HepG2.2.15 cells.METHODS:Antisense-LNA was introduced into HepG2.2.15 cells by cationic liposome-mediated transfection.Supernatants were collected 2,4,6,8,10 days after medication.The concentrations of HBsAg and HBeAg in cell supernatants were tested by ELISA.HBV DNA levels in cellsupernatants were determined by FQ-PCR.Cell toxicity of antisense-LNA and lamivudine was detected by MTT assay.RESULTS:Lamivudine only inhibited viral DNA synthesis.Antisense-LNA effectively inhibited the expression of HBsAg and HBeAg and the replication of HBV DNA(67.69%,59.71%,62.96%,P 0.05) in a time-dependent manner.Both antisense-LNA and lamivudine showed no obvious cell toxicity.CONCLUSION:The anti-HBV effect of antisense-LNA is more effective than that of lamivudine in HepG2.2.15 cells.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第28期2953-2957,共5页 World Chinese Journal of Digestology
基金 广州市科技攻关计划基金资助项目 No.2002Z3-E4081~~
关键词 乙型肝炎病毒 反义锁核酸 拉米夫定 HEPG2.2.15细胞 抗病毒 Hepatitis B virus Antisense LNA Lamivudine HepG2.2.15 cells Antiviral activity
  • 相关文献

参考文献18

  • 1Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a compre- hensive review. AAPS 12005; 7:E61-E77.
  • 2Gruegelsiepe H, Brandt O, Hartmann RK. Anti- sense inhibition of RNase P: mechanistic aspects and application to live bacteria. J Biol Chem 2006; 281:30613-30620.
  • 3Wengel J, Petersen M, Frieden M, Koch T. Chemis- try of locked nucleic acids (LNA): Design, synthe- sis, and bio-physical properties. Lett Pept Sci 2003; 10:237-253.
  • 4Inohara H, Obika S, Imanishi T. 2',4'-BNA deriva- tives bearing an unnatural nucleobase: synthesis and application to triplex-forming oligonucleotides. Nucleic Acids Syrup Ser (Oxf) 2004; (48): 63-64.
  • 5Braasch DA, Liu Y, Corey DR. Antisense inhibi- tion of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res 2002; 30:5160-5167.
  • 6Zoulim F. Therapy of chronic hepatitis B virus in- fection: inhibition of the viral polymerase and other antiviral strategies. Antiviral Res 1999; 44:1-30.
  • 7Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH. Long-term therapy of chronic hepatitis B with lami- vudine. Hepatology 2000; 32:828-834.
  • 8Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in chil- dren with chronic hepatitis B. N Engl J Med 2002; 346:1706-1713.
  • 9Ying C, De Clercq E, Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis Bvirus activity in cell culture. J Viral Hepat 2000; 7: 79-83.
  • 10杨永峰,谭德明,谢玉桃,侯周华.干扰素及拉米夫定抗乙型肝炎病毒的体外实验研究[J].疾病控制杂志,2004,8(3):209-212. 被引量:28

二级参考文献22

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部